MAP2K1 and hereditary clear cell renal cell carcinoma: For instance, epidermal growth factor receptor (EGFR) or mitogen-activated protein kinase (MEK1/2) kinase activity hinders the growth of renal cell carcinoma cells and enhances the growth inhibitory effects of the mammalian target of rapamycin (mTOR) inhibitor rapamycin.